首页> 外国专利> TABLET COMPRISING CRYSTALLINE (S)-ISOPROPYL 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1 (2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE

TABLET COMPRISING CRYSTALLINE (S)-ISOPROPYL 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1 (2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE

机译:包含结晶(S)-异丙基2-(((S)-((((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL) -4-氟代-3-羟基-4-甲基四氢呋喃-2-基)甲氧基)(苯氧基)磷酸基)酰胺基

摘要

Disclosed herein is a tablet comprising crystalline (S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate represented by the formula Sp-4:having XRPD 2-theta-reflections (±0.2°) at 6.1 and 12.7.This tablet is for use in the treatment of a hepatitis C virus infection.
机译:本文公开了包含结晶的(S)-异丙基2-(((S)-((((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1)(2H式Sp-4表示的)-基)-4-氟-3-羟基-4-甲基四氢呋喃-2-基)甲氧基)(苯氧基)磷酰基)氨基)丙酸酯: <图像文件=“ IMGA0001.GIF” he =“ 48” imgContent =“ chem” imgFormat =“ GIF” wi =“ 59” /> 在6.1和12.7时具有XRPD2θ反射(±0.2°)。该片剂用于治疗丙型肝炎病毒感染。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号